Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
Frontiers in Pharmacology
|
July 23, 2024
A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: new insights into emerging mechanisms and therapeutic targets
Priyanka Soni, Navneet Ammal Kaidery, Sudarshana M Sharma, et al.
Frontiers in Aging Neuroscience
|
April 26, 2021
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue
Dmitry M Hushpulian, Navneet Ammal Kaidery, Manuj Ahuja, et al.
Experimental Eye Research
|
April 3, 2018
Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Soumya Navneet, Xuezhi Cui, Jing Zhao, et al.
Science (New York, N.Y.)
|
April 24, 2004
S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function
Kenny K K Chung, Bobby Thomas, Xiaojie Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 30, 2010
Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia
Fangfang Yin, Magali Dumont, Rebecca Banerjee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 14, 2004
Loss of locus coeruleus neurons and reduced startle in parkin null mice
Rainer Von Coelln, Bobby Thomas, Joseph M Savitt, et al.
Plos One
|
February 10, 2011
Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation
Bobby Thomas, Allen S Mandir, Neva West, et al.
Neurochemical Research
|
March 6, 2008
Role of tuberin in neuronal degeneration
Samy L Habib, David Michel, Eliezer Masliah, et al.
Antioxidants (Basel, Switzerland)
|
September 23, 2022
Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease
Manuj Ahuja, Navneet Ammal Kaidery, Debashis Dutta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2006
Neuroprotection by pharmacologic blockade of the GAPDH death cascade
Makoto R Hara, Bobby Thomas, Matthew B Cascio, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
Frontiers in Pharmacology
|
July 23, 2024
A critical appraisal of ferroptosis in Alzheimer's and Parkinson's disease: new insights into emerging mechanisms and therapeutic targets
Priyanka Soni, Navneet Ammal Kaidery, Sudarshana M Sharma, et al.
Frontiers in Aging Neuroscience
|
April 26, 2021
Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue
Dmitry M Hushpulian, Navneet Ammal Kaidery, Manuj Ahuja, et al.
Experimental Eye Research
|
April 3, 2018
Excess homocysteine upregulates the NRF2-antioxidant pathway in retinal Müller glial cells
Soumya Navneet, Xuezhi Cui, Jing Zhao, et al.
Science (New York, N.Y.)
|
April 24, 2004
S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function
Kenny K K Chung, Bobby Thomas, Xiaojie Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
July 30, 2010
Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia
Fangfang Yin, Magali Dumont, Rebecca Banerjee, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 14, 2004
Loss of locus coeruleus neurons and reduced startle in parkin null mice
Rainer Von Coelln, Bobby Thomas, Joseph M Savitt, et al.
Plos One
|
February 10, 2011
Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activation
Bobby Thomas, Allen S Mandir, Neva West, et al.
Neurochemical Research
|
March 6, 2008
Role of tuberin in neuronal degeneration
Samy L Habib, David Michel, Eliezer Masliah, et al.
Antioxidants (Basel, Switzerland)
|
September 23, 2022
Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson's Disease
Manuj Ahuja, Navneet Ammal Kaidery, Debashis Dutta, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2006
Neuroprotection by pharmacologic blockade of the GAPDH death cascade
Makoto R Hara, Bobby Thomas, Matthew B Cascio, et al.
Page
of 7